CONTI, ANDREA
 Distribuzione geografica
Continente #
AS - Asia 115
NA - Nord America 89
EU - Europa 75
SA - Sud America 24
AF - Africa 2
OC - Oceania 2
Totale 307
Nazione #
US - Stati Uniti d'America 86
SG - Singapore 53
CN - Cina 25
BR - Brasile 22
RU - Federazione Russa 19
HK - Hong Kong 17
IT - Italia 13
DE - Germania 9
IE - Irlanda 9
GB - Regno Unito 8
FR - Francia 7
KR - Corea 6
SE - Svezia 6
JP - Giappone 4
AU - Australia 2
FI - Finlandia 2
GE - Georgia 2
ID - Indonesia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CA - Canada 1
CO - Colombia 1
ES - Italia 1
IN - India 1
JM - Giamaica 1
MX - Messico 1
NL - Olanda 1
TG - Togo 1
TR - Turchia 1
UY - Uruguay 1
UZ - Uzbekistan 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 307
Città #
Singapore 22
Hong Kong 17
Dallas 11
Chandler 10
Ashburn 9
Dublin 9
Beijing 4
Falkenstein 4
Falls Church 4
Sindelfingen 4
Jacksonville 3
Mestrino 3
Milan 3
Shimotsuke 3
Southend 3
Chicago 2
Guangzhou 2
Helsinki 2
Houston 2
Jakarta 2
Kent 2
Lawrence 2
New York 2
Princeton 2
Rio de Janeiro 2
Santa Clara 2
Seattle 2
Southport 2
Spoleto 2
Sydney 2
São Paulo 2
Tbilisi 2
Tianjin 2
Verona 2
Wilmington 2
Zhengzhou 2
Americana 1
Araçatuba 1
Belo Horizonte 1
Blumenau 1
Brownsville 1
Brunswick 1
Buritama 1
Campinas 1
Campo Grande 1
Canindé 1
Chennai 1
City of London 1
Congonhas 1
Dhaka 1
Dongguan 1
Essen 1
Fremont 1
Funabashi 1
Harbin 1
Istanbul 1
Jaguarão 1
Jaraguá 1
Johannesburg 1
Kingston 1
Linhares 1
Lomé 1
London 1
Madrid 1
Maicao 1
Maldonado 1
Maringá 1
Mexico City 1
Morada Nova 1
Moscow 1
Nanjing 1
Natal 1
Putian 1
Redmond 1
Redwood City 1
Salvador 1
San Francisco 1
San Secondo Parmense 1
Shenyang 1
Swansea 1
São Francisco do Guaporé 1
Tashkent 1
Uberlândia 1
Washington 1
Totale 199
Nome #
TNF-α inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis 99
Cross-Switch from Etanercept Originator to Biosimilar SB4 and to GP2015 in Patients with Chronic Plaque Psoriasis 50
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasis 48
Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting 36
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience 35
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement 30
Validation and Field Performance of the Italian Version of the Psoriatic Arthritis Screening and Evaluation (PASE) Questionnaire 17
Totale 315
Categoria #
all - tutte 1.657
article - articoli 1.657
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 2 1 1 1 0 0 0 1 0
2021/20226 0 0 0 0 1 0 0 1 2 0 0 2
2022/202343 3 2 3 6 6 7 0 1 8 0 7 0
2023/202458 3 7 8 8 6 4 4 3 0 0 11 4
2024/2025139 7 5 1 25 5 10 9 5 20 20 12 20
2025/202644 28 16 0 0 0 0 0 0 0 0 0 0
Totale 315